The North America Variable Frequency Drive Market is currently worth $4.77 billion and is expected to be worth $5.06 billion by 2032, growing at a CAGR of 6% from 2022 to 2032. North America is known for being more into machines and less into human labor. Variable frequency drives help in smooth sailing with respect …
Monthly Archives: February 2023
Gaskets and Seals Market to be worth US$ 154.7 billion during Forecast 2023 to 2033
According to FMI’s analysis, the gaskets and seals market will grow at a CAGR of 6% during the forecast period. The industry’s value is expected to rise from $86.6 billion in 2023 to $154.7 billion by the end of 2033. The demand curve for gaskets and seals is expected to rise steadily in the coming …
DC Switchgear Market size is surpassing a valuation of US$ 27,963.7 Million from 2022 to 2032
With a year-on-year (Y-o-Y) growth rate of 6.9%, the global DC switchgear market is expected to reach approximately US$ 14,058.4 Million by 2022 end. Furthermore, with rising global energy consumption and demand for DC switchgears in a wide range of applications, the market is expected to grow at a 7.1% CAGR between 2022 and 2032, …
Tipper Body Equipment Market is Expected to Expand at a CAGR of 4.5% during Forecast 2022 to 2032
In 2021, the global tipper body equipment market was valued at approximately US$ 3,445.30 million, with a projected value of US$ 4,2221.50 million in 2022. Furthermore, as tippers become more prevalent in industries such as mining, construction, and waste management, overall sales of tipper body equipment are expected to grow at a 4.5% CAGR between …
Continuous Glucose Monitoring Systems Market to reach a valuation of ~US$ 3.0 Billion by 2032
[Report of 261 Pages] The market for continuous glucose monitoring systems is anticipated to reach a valuation of US$ 1.1 billion in 2022 and then grow at a CAGR of 10.8% to US$ 3.0 billion by the end of 2032. In 2021, the global continuous glucose monitoring systems market will be dominated by sensors, with a share …
High Content Screening Market is projected to expand at a CAGR of 5.9% over the forecast to 2031
The increasing demand for cell visualization and quantification using advance technique has been enabling growth in the global high content market. As per a study by Future Market Insights (FMI), driven by rising application in pharmaceutical and biotech companies, the market is poised to reach a valuation of US$ 1.5 Bn by the end of …
Real Time Continuous Microbiological Monitoring Systems Market Growth Forecast To 2030
Pharmaceutical and biotechnology companies who produce medicine and biotech products are concern about airborne microbial contamination. Traditionally, these companies use active air samplers or settling plate method to detect the airborne microbial contamination. But, this method may require at least four to ten days to detect the microbial contamination in the lab. Real time continuous microbiological …
Ocular Drug Delivery Systems sales will total US$ 27.82 Bn by 2031
[250 Pages Report] According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably, enabling the market to surpass US$ 14,471.2 Mn in valuation by the end of 2021. The market is forecast to exhibit 6.8% CAGR between 2021 and 2031. Ocular drug delivery systems are designed for dispensing drug, biologic, biopharmaceutical, and botanical …
Continue reading “Ocular Drug Delivery Systems sales will total US$ 27.82 Bn by 2031”
Andersen Tawil Syndrome Treatment Market is projected to reach US$ 4.2 Billion by 2033
As per a recently published study by Future Market Insights, the global Andersen Tawil syndrome treatment market is expected to surpass an impressive valuation of US$ 1.9 Billion in 2023 and is projected to reach US$ 4.2 Billion by 2033, with a CAGR of 8.26%. Rising government assistance, provision of incentives to pharmaceutical companies, increasing awareness among …
Restrictive Cardiomyopathy Treatment Market is expected to garner a market value of US$ 100 Million in 2023
The global restrictive cardiomyopathy treatment market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of 6% in the forecast period 2023-2033. The market for Restrictive Cardiomyopathy Treatment registered a CAGR of 4% in the historical period …